{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:04:58Z","timestamp":1765731898432},"reference-count":20,"publisher":"Hindawi Limited","issue":"10","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3304,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1742-1241.2006.01104.x","type":"journal-article","created":{"date-parts":[[2006,8,15]],"date-time":"2006-08-15T09:19:48Z","timestamp":1155633588000},"page":"1210-1217","source":"Crossref","is-referenced-by-count":39,"title":["Gout Assessment Questionnaire: initial results of reliability, validity and responsiveness"],"prefix":"10.1155","volume":"60","author":[{"given":"H. H.","family":"COLWELL","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. J.","family":"HUNT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D. J.","family":"PASTA","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"PALO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. D.","family":"MATHIAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"JOSEPH-RIDGE","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2006,8,15]]},"reference":[{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1016\/S0149-2918(03)80158-3","article-title":"A literature review of the epidemiology and treatment of acute gout","volume":"25","author":"Kim","year":"2003","journal-title":"Clin Ther"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1136\/ard.58.10.611","article-title":"Gout","volume":"58","author":"Perkins","year":"1999","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB3|cit3","first-page":"925","article-title":"Gout and hyperuricemia","volume":"59","author":"Harris","year":"1999","journal-title":"Am Fam Physician"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0095-4543(21)00435-8","article-title":"Gout and pseudogout","volume":"20","author":"Argawal","year":"1993","journal-title":"Prim Care"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB5|cit5","volume-title":"Current estimates from the national health interview survey. National Center for Health Statistics","author":"Adams","year":"1996"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0002-9343(87)90441-4","article-title":"Asymptomatic hyperuricemia: risks and consequences in the Normative Aging Study","volume":"82","author":"Campion","year":"1987","journal-title":"Am J Med"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1001\/jama.1991.03470210072035","article-title":"Incidence and risk factors for gout in white men","volume":"266","author":"Roubenoff","year":"1991","journal-title":"JAMA"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB8|cit8","first-page":"2403","article-title":"Epidemiology of gout: is the incidence rising?","volume":"29","author":"Arromdee","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB9|cit9","first-page":"484","article-title":"Preliminary core set of domains and reporting requirements for longitudinal observational studies in rheumatology","volume":"26","author":"Wolfe","year":"1999","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB10|cit10","first-page":"873","article-title":"Patient perspective in outcome assessments - perceptions or something more?","volume":"30","author":"Kvien","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB11|cit11","first-page":"2452","article-title":"Outcome measures for acute and chronic gout","volume":"32","author":"Schumacher","year":"2005","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB12|cit12","unstructured":"Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research arthritis advisory committee http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/04\/transcripts\/2004-4044T1.htm"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1002\/art.20935","article-title":"Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout","volume":"52","author":"Becker","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"9 Suppl.","key":"10.1111\/j.1742-1241.2006.01104.x-BIB14|cit14","first-page":"S335","article-title":"A phase 2, long term open-label safety and efficacy study of febuxostat, a novel non-purine, selective inhibitor of xanthine oxidase [abstract]","volume":"50","author":"Schumacher","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"Suppl. III","key":"10.1111\/j.1742-1241.2006.01104.x-BIB15|cit15","first-page":"498","article-title":"Long-term safety and efficacy of febuxostat, a novel non-purine selective inhibitor of xanthine oxidase, in subjects with hyperuricemia and gout [abstract]","volume":"64","author":"Schumacher","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB16|cit16","volume-title":"SF-35 Health Survey: Manual and Interpretation Guide","author":"Ware","year":"1993"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-Item Short-Form Health Survey (SF-36): conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB18|cit18","unstructured":"SAS Institute, Inc SAS System for Windows SAS Institute, Inc"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB19|cit19","volume-title":"Psychometric theory","author":"Nunnaly","year":"1978"},{"key":"10.1111\/j.1742-1241.2006.01104.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0021-9681(87)90069-5","article-title":"Measuring change over time: assessing the usefulness of evaluative instruments","volume":"40","author":"Guyatt","year":"1987","journal-title":"J Chronic Dis"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1742-1241.2006.01104.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1742-1241.2006.01104.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:04:35Z","timestamp":1643349875000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1742-1241.2006.01104.x"}},"subtitle":["GOUT ASSESSMENT QUESTIONNAIRE"],"short-title":[],"issued":{"date-parts":[[2006,8,15]]},"references-count":20,"journal-issue":{"issue":"10"},"URL":"https:\/\/doi.org\/10.1111\/j.1742-1241.2006.01104.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8,15]]}}}